US-based Intrivo has introduced On/Go, an at-home rapid Covid-19 antigen self-test. The company says the test can deliver results with 95% accuracy in ten minutes. On/Go has already received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA). Intrivo also launched a companion app that will enable the users to view, track and share test results. Users can order the test online at different e-commerce websites. Additionally, Intrivo received a US Department of Defense contract to distribute On/Go tests to 25,000 locations across the country.
Israel Defense Forces (IDF) has bought hundreds of remote Covid-19 testing devices, reports The Jerusalem Post. Developed by local start-up Tyto Care, the device will allow people to test their heart rate, body temperature as well as examine their heart, lungs and throat, ears, skin, abdomen, heart rate and body temperature. Results will be shown via the company’s companion app. According to the news report, the procurement will help shift patients with mild Covid-19 infections to home care, reducing overload in hospitals as they monitor their health using the remote Tyto Care device. More than 150 hospitals and clinics across the world already use the device for remote treatment.
Go deeper with GlobalData
Aptar CSP Technologies has secured a $19m contract from the US Government to boost the domestic production capacity of its Activ‐Film technology, which is used to protect Covid‐19 test kits. Activ‐Film technology is integrated into diagnostic dipsticks and lateral flow cassettes to absorb moisture and prevent other environmental degradants from impacting the integrity of the test kits. The funding will be used to purchase equipment to increase production of Activ‐Film material at Aptar’s Auburn, Alabama plant.
